The antimutagenicity of 2-substituted selenazolidine-4-(R)-carboxylic acids

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 627, Issue 2, 2007, Pages 136-145

  El Sayed, Wael M ^a   Hussin, Warda A ^a   Franklin, Michael R ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

Acridine orange; Antimutagenic; Benzo a pyrene; CYP1A inhibition; Salmonella typhimurium TA98; Selenazolidine 4 (R) carboxylic acids; Selenocysteine prodrugs

Indexed keywords

2 (2' HYDROXYPHENYL)SELENAZOLIDINE 4 CARBOXYLIC ACID; 2 BUTYLSELENAZOLIDINE 4 CARBOXYLIC ACID; 2 CYCLOHEXYLSELENAZOLIDINE 4 CARBOXYLIC ACID; 2 METHYLSELENAZOLIDINE 4 CARBOXYLIC ACID; 2 OXOSELENAZOLIDINE 4 CARBOXYLIC ACID; 2 PHENYLSELENAZOLIDINE 4 CARBOXYLIC ACID; ACRIDINE ORANGE; ANTIMUTAGENIC AGENT; BENZO[A]PYRENE; CARBOXYLIC ACID DERIVATIVE; CYTOCHROME P450 1A; MUTAGENIC AGENT; PRODRUG; SELENIUM; SELENIUM DERIVATIVE; SELENOCYSTEINE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTERIAL STRAIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; ENZYME INHIBITION; MUTAGENICITY; MUTANT; NONHUMAN; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM;

ANTIMUTAGENIC AGENTS; CARBOXYLIC ACIDS; CYTOCHROME P-450 CYP1A1; MUTAGENICITY TESTS; ORGANOSELENIUM COMPOUNDS; SALMONELLA TYPHIMURIUM;

MAMMALIA; SALMONELLA TYPHIMURIUM;

EID: 33846249245     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2006.11.002     Document Type: Article

References (38)

1. Jacobs M.M., Matney T.S., and Griffin A.C. Inhibitory effects of selenium of the mutagenicity of 2-acetylaminofluorene (AAF) and AAF derivatives. Cancer Lett. 2 (1977) 319-322
2. Ames B.N., Durston W.E., Yamasaki E., and Lee F.D. Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection. Proc. Natl. Acad. Sci. U.S.A. 70 (1973) 2281-2285
3. Martin S.E., Adams G.H., Schillac M., and Milner J.A. Antimutagenic effect of selenium on acridine orange and 7,12-dimethylbenz[alpha]anthracene in the Ames Salmonella/microsomal system. Mutat. Res. 82 (1981) 41-46
4. Teel R.W. A comparison of the effect of selenium on the mutagenicity and metabolism of benzo[a]pyrene in rat and hamster liver S9 activation systems. Cancer Lett. 24 (1984) 281-289
5. Prasanna P., Jacobs M.M., and Yang S.K. Selenium inhibition of benzo[a]pyrene, 3-methylcholanthrene, and 3-methylcholanthrylene mutagenicity in Salmonella typhimurium strains TA98 and TA100. Mutat. Res. 190 (1987) 101-105
6. Chortyk O.T., Baker J.L., and Chamberlain W.L. Selenium-mediated reduction in the mutagenicity of cigarette smoke. Environ. Mol. Mutagen. 11 (1988) 369-378
7. Francis A.R., Shetty T.K., and Bhattacharya R.K. Effect of certain trace elements on the mutagenicity of N-methyl-N′-nitro-N-nitrosoguanidine. Toxicol. Lett. 42 (1988) 193-198
8. Balansky R. Effects of sodium selenite and caffeine on mutagenesis induced by N-methyl-N-nitrosourea, N-methyl-N′-nitro-N-nitrosoguanidine and aflatoxin B1 in S. typhimurium. Mutat. Res. 269 (1992) 307-317
9. Lin W.S., Scrimshaw C., and Kapoor M. Selenium suppresses the metabolism of benzo[a]pyrene by rat-liver extracts, and exerts a dual effect on its mutagenicity. Xenobiotica 14 (1984) 893-902
10. Teel R.W., and Kain S.R. Selenium modified mutagenicity and metabolism of benzo[a]pyrene in an S9-dependent system. Mutat. Res. 127 (1984) 9-14
11. Ip C. Prophylaxis of mammary neoplasia by selenium supplementation in the initiation and promotion phases of chemical carcinogenesis. Cancer Res. 41 (1981) 4386-4390
12. Ip C., and Sinha D. Anticarcinogenic effect of selenium in rats treated with dimethylbenz[a]anthracene and fed different levels and types of fat. Carcinogenesis 2 (1981) 435-438
13. Lane H.W., Teer P., Dukes J., Johnson J., and White M.T. The effect of four chemical forms of selenium on mammary tumor incidence in BALB/c female mice treated with 7-12-dimethylbenz[a]anthracene. Cancer Lett. 50 (1990) 39-44
14. Ip C. Factors influencing the anticarcinogenic efficacy of selenium in dimethylbenz[a]anthracene-induced mammary tumorigenesis in rats. Cancer Res. 41 (1981) 2683-2686
15. El-Bayoumy K., Upadhyaya P., Desai D.H., Amin S., and Hecht S.S. Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone tumorigenicity in mouse lung by the synthetic organoselenium compound 1,4-phenylenebis(methylene)selenocyanate. Carcinogenesis 6 (1993) 1111-1113
16. Li L., Xie Y., El-Sayed W.M., Szakacs J.G., Franklin M.R., and Roberts J.C. Chemopreventive activity of selenocysteine prodrugs against tobacco-derived nitrosamine (NNK) induced lung tumors in the A/J mouse. J. Biochem. Mol. Toxicol. 19 (2005) 396-405
17. Curphey T.J., Kuhlmann E.T., Roebuck B.D., and Longnecker D.S. Inhibition of pancreatic and liver carcinogenesis in rats by retinoid- and selenium-supplemented diets. Pancreas 3 (1988) 36-40
18. Ip C., and White G. Mammary cancer chemoprevention by inorganic and organic selenium: single agent treatment or in combination with vitamin E and their effects on in vitro immune functions. Carcinogenesis 8 (1987) 1763-1766
19. Ip C., Hayes C., Budnick R.M., and Ganther H.E. Chemical form of selenium, critical metabolites, and cancer prevention. Cancer Res. 51 (1991) 595-600
20. Ip C., and Ganther H.E. Comparison of selenium and sulfur analogs in cancer prevention. Carcinogenesis 13 (1992) 1167-1170
21. Ip C., Zhu Z., Thompson H.J., Lisk D., and Ganther H.E. Chemoprevention of mammary cancer with Se-allylselenocysteine and other selenoamino acids in the rat. Anticancer Res. 19 (1999) 2875-2880
22. Amantana A., Santana-Rios G., Butler J.A., Xu M., Whanger P.D., and Dashwood R.H. Antimutagenic activity of selenium-enriched green tea toward the heterocyclic amine 2-amino-3-methylimidazo[4,5-f]quinoline. Biol. Trace Elem. Res. 86 (2002) 177-191
23. El-Bayoumy K. Effects of organoselenium compounds on induction of mouse forestomach tumors by benzo(a)pyrene. Cancer Res. 45 (1985) 3631-3635
24. El-Bayoumy K., Chae Y.H., Upadhyaya P., Meschter C., Cohen L.A., and Reddy B.S. Inhibition of 7,12-dimethylbenz(a)anthracene-induced tumors and DNA adduct formation in the mammary glands of female Sprague-Dawley rats by the synthetic organoselenium compound 1,4-phenylenebis(methylene)selenocyanate. Cancer Res. 52 (1992) 2402-2407
25. Ip C., Vadhanavikit S., and Ganther H.E. Cancer chemoprevention by aliphatic selenocyanates: effect of chain length on inhibition of mammary tumors and DMBA adducts. Carcinogenesis 16 (1995) 35-38
26. Ip C., Lisk D.J., Ganther H.E., and Thompson H.J. Triphenylselenonium and diphenylselenide in cancer chemoprevention: comparative studies of anticarcinogenic efficacy, tissue selenium levels and excretion profile. Anticancer Res. 17 (1997) 3195-3199
27. Ip C., Lisk D.J., and Ganther H.E. Activities of structurally-related lipophilic selenium compounds as cancer chemopreventive agents. Anticancer Res. 18 (1998) 4019-4025
28. Nayini J., El-Bayoumy K., Sugie S., Cohen L.A., and Reddy B.S. Chemoprevention of experimental mammary carcinogenesis by the synthetic organoselenium compound, benzylselenocyanate, in rats. Carcinogenesis 10 (1989) 509-512
29. Prokopczyk B., Amin S., Desai D.H., Kurtzke C., Upadhyaya P., and El-Bayoumy K. Effects of 1,4-phenylenebis(methylene)selenocyanate and selenomethionine on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced tumorigenesis in A/J mouse lung. Carcinogenesis 18 (1997) 1855-1857
30. Rao C.V., Wang C.Q., Simi B., Rodriguez J.G., Cooma I., El-Bayoumy K., and Reddy B.S. Chemoprevention of colon cancer by a glutathione conjugate of 1,4-phenylenebis(methylene)selenocyanate, a novel organoselenium compound with low toxicity. Cancer Res. 61 (2001) 3647-3652
31. Reddy B.S., Rivenson A., Kulkarni N., Upadhyaya P., and El-Bayoumy K. Chemoprevention of colon carcinogenesis by the synthetic organoselenium compound 1,4-phenylenebis(methylene)selenocyanate. Cancer Res. 52 (1992) 5635-5640
32. Sugie S., Reddy B.S., El-Bayoumy K., and Tanaka T. Inhibition by dietary benzylselenocyanate of hepatocarcinogenesis induced by azoxymethane in Fischer 344 rats. Jpn. J. Cancer Res. 80 (1989) 952-957
33. Tanaka T., Reddy B.S., and El-Bayoumy K. Inhibition by dietary organoselenium, p-methoxybenzene-selenol, of hepatocarcinogenesis induced by azoxymethane in rats. Jpn. J. Cancer Res. 76 (1985) 462-467
34. Tanaka T., Makita H., Kawabata K., Mori H., and El-Bayoumy K. 1,4-Phenylenebis(methylene) selenocyanate exerts exceptional chemopreventive activity in rat tongue carcinogenesis. Cancer Res. 57 (1997) 3644-3648
35. Xie Y., Short M.D., Cassidy P.B., and Roberts J.C. Selenazolidines as novel organoselenium delivery agents. Bioorg. Med. Chem. Lett. 11 (2001) 2911-2915
36. Short M.D., Xie Y., Li L., Cassidy P.D., and Roberts J.C. Characteristics of selenazolidine prodrugs of selenocysteine: toxicity and glutathione peroxidase induction in V79 cells. J. Med. Chem. 46 (2003) 3308-3313
37. Pillai S.P., Pillai C.A., Shankel D.M., and Mitscher L.A. The ability of certain antimutagenic agents to prevent development of antibiotic resistance. Mutat. Res. 496 (2001) 61-73
38. El-Sayed W.M., Aboul-Fadl T., Roberts J.C., Lamb J.G., and Franklin M.R. Murine hepatoma (Hepa1c1c7) cells: a responsive in vitro system for chemoprotective enzyme induction by organoselenium compounds. Toxicol. In Vitro 21 (2007) 157-164